🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the study is the evaluation of efficacy and safety of obin...
Status
Terminated
Location
Centrum Onkologii - Instytut im. Marii Skłodowskiej- Curie Klinika Nowotworów Układu Chłonnego
Start Date
2018-05-14
Trial ID
NCT03229382
Treatments Being Tested
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
Study hypothesis: Simultaneous FMC-Alemtuzumab administration followed by A...
Status
Completed
Location
University Hospital Cologne
Start Date
2010-06
Trial ID
NCT01186640
Treatments Being Tested
The study aims to compare two application forms (pre-filled syringe and On-...
Status
Completed
Location
Research Site
Start Date
2018-06-25
Trial ID
NCT03619993
Treatments Being Tested
This is an open label, multicenter, dose escalation, phase Ib study to dete...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-10
Trial ID
NCT02741388
Treatments Being Tested
Tislelizumab combined with chemotherapy sequential neoadjuvant therapy for ...
Status
Active Not Recruiting
Location
Sichuan Cancer Hospital and Research Institute
Start Date
2021-07-01
Trial ID
NCT05189730
Treatments Being Tested
Phase 2 Study of Abbreviated 3 Cycles of Rituximab plus CHOP (Cyclophospham...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12-07
Trial ID
NCT03399747
Treatments Being Tested
This is a multicenter, prospective, single-arm, phase 2 clinical trial desi...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2024-09-12
Trial ID
NCT06288360
Treatments Being Tested
This is a prospective, single-arm clinical study to evaluate the efficacy a...
Status
Completed
Location
Zhejiang Cancer Hospital
Start Date
2022-02-01
Trial ID
NCT07493486
Treatments Being Tested
Taxane-based agents are widely used in the treatment of esophageal squamous...
Status
Completed
Location
West China Hospital
Start Date
2026-04-01
Trial ID
NCT07549269